Madrigal Short Term Investments vs Total Liab Analysis

MDGL Stock  USD 205.13  2.91  1.40%   
Madrigal Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Madrigal Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Madrigal Pharmaceuticals is a good investment. Please check the relationship between Madrigal Pharmaceuticals Short Term Investments and its Total Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.

Short Term Investments vs Total Liab

Short Term Investments vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Madrigal Pharmaceuticals Short Term Investments account and Total Liab. At this time, the significance of the direction appears to have strong relationship.
The correlation between Madrigal Pharmaceuticals' Short Term Investments and Total Liab is 0.61. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Total Liab in the same time period over historical financial statements of Madrigal Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Madrigal Pharmaceuticals' Short Term Investments and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Madrigal Pharmaceuticals are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Short Term Investments i.e., Madrigal Pharmaceuticals' Short Term Investments and Total Liab go up and down completely randomly.

Correlation Coefficient

0.61
Relationship DirectionPositive 
Relationship StrengthSignificant

Short Term Investments

Short Term Investments is an item under the current assets section of Madrigal Pharmaceuticals balance sheet. It contains any investments Madrigal Pharmaceuticals undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Madrigal Pharmaceuticals can easily liquidate in the marketplace.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from Madrigal Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Madrigal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.At this time, Madrigal Pharmaceuticals' Sales General And Administrative To Revenue is quite stable compared to the past year. Enterprise Value is expected to rise to about 4.6 B this year, although the value of Selling General Administrative will most likely fall to about 102.7 K.

Madrigal Pharmaceuticals fundamental ratios Correlations

0.95-0.360.890.810.76-0.360.750.720.32-0.34-0.2-0.590.690.420.180.471.00.930.810.321.00.70.74-0.5-0.32
0.95-0.410.860.610.52-0.410.530.480.18-0.34-0.35-0.330.450.50.030.430.950.920.610.180.940.470.5-0.54-0.31
-0.36-0.41-0.580.08-0.131.0-0.22-0.15-0.24-0.220.29-0.24-0.18-0.31-0.06-0.23-0.39-0.32-0.06-0.24-0.39-0.04-0.110.81-0.23
0.890.86-0.580.650.65-0.580.750.70.2-0.38-0.26-0.430.650.420.020.520.880.760.650.20.880.490.54-0.68-0.34
0.810.610.080.650.940.080.890.910.38-0.40.14-0.950.880.130.310.40.790.690.930.380.790.890.88-0.12-0.4
0.760.52-0.130.650.94-0.140.950.960.49-0.220.19-0.920.940.10.420.380.760.610.930.490.760.950.96-0.24-0.22
-0.36-0.411.0-0.580.08-0.14-0.23-0.16-0.24-0.210.29-0.24-0.18-0.31-0.06-0.23-0.4-0.33-0.07-0.24-0.39-0.05-0.120.81-0.23
0.750.53-0.220.750.890.95-0.230.990.46-0.260.11-0.870.920.130.350.50.750.570.890.460.750.810.83-0.35-0.24
0.720.48-0.150.70.910.96-0.160.990.46-0.270.14-0.90.960.110.370.460.720.540.90.460.720.840.85-0.25-0.26
0.320.18-0.240.20.380.49-0.240.460.460.520.48-0.410.43-0.340.930.460.370.40.41.00.370.50.51-0.160.51
-0.34-0.34-0.22-0.38-0.4-0.22-0.21-0.26-0.270.520.130.32-0.22-0.180.46-0.3-0.26-0.21-0.190.52-0.26-0.15-0.13-0.130.99
-0.2-0.350.29-0.260.140.190.290.110.140.480.13-0.30.12-0.950.530.17-0.2-0.050.010.48-0.190.250.220.260.11
-0.59-0.33-0.24-0.43-0.95-0.92-0.24-0.87-0.9-0.410.32-0.3-0.870.04-0.39-0.31-0.57-0.45-0.87-0.41-0.57-0.87-0.85-0.050.32
0.690.45-0.180.650.880.94-0.180.920.960.43-0.220.12-0.870.140.360.290.680.530.860.430.690.840.85-0.25-0.22
0.420.5-0.310.420.130.1-0.310.130.11-0.34-0.18-0.950.040.14-0.4-0.090.420.230.26-0.340.420.050.08-0.31-0.16
0.180.03-0.060.020.310.42-0.060.350.370.930.460.53-0.390.36-0.40.470.220.260.280.930.220.470.450.130.44
0.470.43-0.230.520.40.38-0.230.50.460.46-0.30.17-0.310.29-0.090.470.450.40.250.460.450.250.26-0.11-0.29
1.00.95-0.390.880.790.76-0.40.750.720.37-0.26-0.2-0.570.680.420.220.450.930.810.371.00.70.74-0.53-0.23
0.930.92-0.320.760.690.61-0.330.570.540.4-0.21-0.05-0.450.530.230.260.40.930.670.40.930.610.64-0.47-0.19
0.810.61-0.060.650.930.93-0.070.890.90.4-0.190.01-0.870.860.260.280.250.810.670.40.810.880.89-0.26-0.17
0.320.18-0.240.20.380.49-0.240.460.461.00.520.48-0.410.43-0.340.930.460.370.40.40.370.50.51-0.160.51
1.00.94-0.390.880.790.76-0.390.750.720.37-0.26-0.19-0.570.690.420.220.451.00.930.810.370.710.74-0.53-0.23
0.70.47-0.040.490.890.95-0.050.810.840.5-0.150.25-0.870.840.050.470.250.70.610.880.50.711.0-0.14-0.15
0.740.5-0.110.540.880.96-0.120.830.850.51-0.130.22-0.850.850.080.450.260.740.640.890.510.741.0-0.22-0.14
-0.5-0.540.81-0.68-0.12-0.240.81-0.35-0.25-0.16-0.130.26-0.05-0.25-0.310.13-0.11-0.53-0.47-0.26-0.16-0.53-0.14-0.22-0.16
-0.32-0.31-0.23-0.34-0.4-0.22-0.23-0.24-0.260.510.990.110.32-0.22-0.160.44-0.29-0.23-0.19-0.170.51-0.23-0.15-0.14-0.16
Click cells to compare fundamentals

Madrigal Pharmaceuticals Account Relationship Matchups

Madrigal Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets442.1M287.0M273.3M362.6M640.5M672.6M
Total Stockholder Equity416.6M240.0M196.1M197.4M405.3M425.6M
Common Stock Shares Outstanding15.4M15.4M16.5M17.1M18.7M19.6M
Liabilities And Stockholders Equity442.1M287.0M273.3M362.6M640.5M672.6M
Other Stockholder Equity639.6M665.4M863.5M1.2B1.7B1.8B
Total Liab25.5M47.0M77.2M165.2M235.2M247.0M
Other Current Liab23.6M45.2M55.0M91.5M90.0M94.5M
Total Current Liabilities25.1M46.6M76.8M115.9M118.5M124.5M
Property Plant And Equipment Net1.9M1.8M1.6M1.2M3.3M2.1M
Net Debt(46.0M)(53.2M)(35.5M)(281.7M)17.3M18.1M
Retained Earnings(223.2M)(425.5M)(667.3M)(962.7M)(1.3B)(1.3B)
Accounts Payable1.2M1.0M21.4M23.8M28.0M29.4M
Cash46.7M54.0M36.3M331.5M99.9M99.8M
Non Current Assets Total1.9M1.8M1.6M1.2M3.3M2.4M
Non Currrent Assets Other1.9M1.8M797K1.2M1.4M719.9K
Cash And Short Term Investments439.0M284.1M270.3M358.8M634.1M665.8M
Short Term Investments392.3M230.1M234.1M27.2M534.2M560.9M
Other Current Assets1.2M1.0M1.3M2.6M3.2M3.3M
Property Plant And Equipment Gross1.9M1.8M1.6M1.2M3.3M2.1M
Total Current Assets440.2M285.2M271.7M361.4M637.3M669.1M
Accumulated Other Comprehensive Income216K47K(80K)(32K)468K491.4K
Non Current Liabilities Total361K468K387K49.3M116.7M122.5M
Net Tangible Assets416.6M240.0M196.1M197.4M227.0M184.4M
Retained Earnings Total Equity(223.2M)(425.5M)(667.3M)(962.7M)(866.4M)(823.1M)
Capital Surpluse639.6M665.4M863.5M1.2B1.3B1.4B
Property Plant Equipment1.2M1.0M1.6M601K691.2K734.4K
Net Invested Capital416.6M240.0M196.1M246.7M520.8M358.2M
Net Working Capital415.1M238.6M194.8M245.5M518.7M356.9M

Madrigal Pharmaceuticals Investors Sentiment

The influence of Madrigal Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Madrigal. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Madrigal Pharmaceuticals' public news can be used to forecast risks associated with an investment in Madrigal. The trend in average sentiment can be used to explain how an investor holding Madrigal can time the market purely based on public headlines and social activities around Madrigal Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Madrigal Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Madrigal Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Madrigal Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Madrigal Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Madrigal Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Madrigal Pharmaceuticals' short interest history, or implied volatility extrapolated from Madrigal Pharmaceuticals options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Madrigal Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
Note that the Madrigal Pharmaceuticals information on this page should be used as a complementary analysis to other Madrigal Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Madrigal Stock analysis

When running Madrigal Pharmaceuticals' price analysis, check to measure Madrigal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Madrigal Pharmaceuticals is operating at the current time. Most of Madrigal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Madrigal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Madrigal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Madrigal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Madrigal Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.98)
Return On Assets
(0.40)
Return On Equity
(0.89)
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.